Abstract
Aim:
To examine the in vitro antitumor activity of resveratrol against multiple myeloma (MM) cell lines (RPMI 8226, U266, and KM3), and the mechanisms involved.
Methods:
The growth inhibition of resveratrol was determined by 3-(4, 5-dimethyl-2-thiazyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. The effect of resveratrol on the apoptosis was investigated by combined annexin V-propidium iodide staining. The effect of resveratrol on the invasion through Matrigel matrix was detected by transwell invasion analyses. The activity of matrix metalloproteinase (MMP)-2 and -9 proteins were determined by gelatin zymography analysis. The expression of MMP-2, MMP-9, Bcl-2, Bcl-xL, XIAP and Bax protein were detected using Western blotting analysis.
Results:
Resveratrol inhibited proliferation of MM cells in a dose- and time-dependent manner. Incubation of MM cells with resveratrol resulted in apoptotic cell death. Resveratrol down-regulated the expression of the antiapoptotic proteins Bcl-2, Bcl-xL and XIAP and up-regulated the expression of the proapoptotic protein Bax. Furthermore, resveratrol inhibited invasion of RPMI 8226, U266, and KM3 cells with IC50 values of 64±8 umol/L, 93±11 umol/L, and 153±11 umol/L, respectively. Resveratrol inhibited the constitutive expression of MMP-2 and -9 proteins of MM cells and suppressed its gelatinolytic activity.
Conclusion:
Resveratrol inhibits the proliferation of MM cells by inducing apoptotic cell death. Resveratrol also inhibits MM cell invasion. The inhibition of invasion may be associated with the attenuation of the enzymatic activities of MMP-2 and -9.
Similar content being viewed by others
Article PDF
References
Anderson KC, Hamblin TJ, Traynor A . Management of multiple myeloma today. Semin Hematol 1999; 36: 3–8.
Zoberi I, Bradbury CM, Curry HA, Bisht KS, Goswami PC, Roti Roti JL, et al. Radiosensitizing and anti-proliferative effects of resveratrol in two human cervical tumor cell lines. Cancer Lett 2002; 175: 165–73.
Bhat KP, Pezzuto JM . Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells. Cancer Res 2001; 61: 6137–44.
Dorrie J, Gerauer H, Wachter Y, Zunino SJ . Resveratrol induces apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. Cancer Res 2001; 61: 4731–9.
Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997; 275: 218–20.
Folgueras AR, Pendas AM, Sanchez LM, Lopez-Otin C . Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 2004; 48: 411–24.
Van Valckenborgh E, Croucher PI, De Raeve H, Carron C, De Leenheer E, Blacher S, et al. Multifunctional role of matrix metalloproteinases in multiple myeloma: a study in the 5T2MM mouse model. Am J Pathol 2004; 165: 869–78.
Fremont L . Biological effects of resveratrol. Life Sci 2000; 66: 663–73.
Jang M, Pezzuto JM . Cancer chemopreventive activity of resveratrol. Drugs Exp Clin Res 1999; 25: 65–77.
Cao Y, Fu ZD, Wang F, Liu HY, Han R . Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants. J Asian Nat Prod Res 2005; 7: 205–13.
Tseng SH, Lin SM, Chen JC, Su YH, Huang HY, Chen CK, et al. Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin Cancer Res 2004; 10: 2190–202.
Gusman J, Malonne H, Atassi G . A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis 2001; 22: 1111–7.
Jazirehi AR, Bonavida B . Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. Mol Cancer Ther 2004; 3: 71–84.
Vihinen P, Ala-aho R, Kahari VM . Matrix metalloproteinases as therapeutic targets in cancer. Curr Cancer Drug Targets 2005; 5: 203–20.
Vacca A, Ribatti D, Presta M, Minischetti M, Ria R, et al. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 1999; 93: 3064–73.
Vacca A, Ribatti D, Iuriaro M, Albini A, Minischetti M, Bussolino F, et al. Human lymphoblastoid cells produces extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis. Int J Clin Lab Res 1998; 28: 55–68.
Narla RK, Dong Y, Klis DT, TUckun FM . Bis(4,7-dimethyl-1, 10-phenanthroline) sulfatooxovanadium(IV) as a novel antileukemic agent with matrix metalloproteinase inhibitory activity. Clin Cancer Res 2001; 7: 1094–101.
Marier JF, Vachon P, Gritsas A, Zhang J, Moreau JP, Ducharme MP . Metabolism and disposition of resveratrol in rats: Extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther 2002; 302: 369–73.
Vitaglione P, Sforza S, Galaverna G, Ghidini C, Caporaso N, Vescovi P, et al. Bioavailability of trans-resveratrol from red wine in humans. Mol Nutr Food Res 2005; 49: 495–504.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sun, Cy., Hu, Y., Guo, T. et al. Resveratrol as a novel agent for treatment of multiple myeloma with matrix metalloproteinase inhibitory activity. Acta Pharmacol Sin 27, 1447–1452 (2006). https://doi.org/10.1111/j.1745-7254.2006.00343.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2006.00343.x
Keywords
This article is cited by
-
The effects of resveratrol on the expression of VEGF, TGF-β, and MMP-9 in endometrial stromal cells of women with endometriosis
Scientific Reports (2021)
-
Resveratrol ameliorates experimental periodontitis in diabetic mice through negative regulation of TLR4 signaling
Acta Pharmacologica Sinica (2015)
-
Suppression of essential pro-inflammatory signaling pathways by natural agents for the therapy of Multiple Myeloma
Phytochemistry Reviews (2014)
-
Effects of resveratrol on oral squamous cell carcinoma (OSCC) cells in vitro
Journal of Cancer Research and Clinical Oncology (2014)
-
Potential of Resveratrol Analogues as Antagonists of Osteoclasts and Promoters of Osteoblasts
Calcified Tissue International (2010)